Cocrystal Pharma, Inc. (NASDAQ:COCP) Sees Large Increase in Short Interest

Cocrystal Pharma, Inc. (NASDAQ:COCP) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 27,900 shares, a growth of 59.4% from the December 15th total of 17,500 shares. Based on an average daily trading volume, of 42,300 shares, the short-interest ratio is presently 0.7 days. Currently, 0.4% of the company’s stock are sold short.

Cocrystal Pharma Stock Down 1.5 %

Shares of COCP stock traded down $0.03 during trading on Friday, reaching $1.98. The company’s stock had a trading volume of 24,060 shares, compared to its average volume of 45,577. Cocrystal Pharma has a one year low of $1.33 and a one year high of $3.26. The business has a fifty day moving average price of $2.15 and a 200-day moving average price of $2.00. The company has a market cap of $20.14 million, a price-to-earnings ratio of -1.07 and a beta of 1.53.

Cocrystal Pharma Company Profile

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.